BRIEF published on 06/18/2024 at 07:05, 2 years ago EUROAPI et Priothera s'associent au CDMO pour faire progresser le projet d'oncologie CDMO Oncologie EUROAPI Priothera Mocravimod
BRIEF published on 06/18/2024 at 07:05, 2 years ago EUROAPI and Priothera Enter CDMO Collaboration to Advance Oncology Project CDMO Oncology EUROAPI Priothera Mocravimod
PRESS RELEASE published on 06/18/2024 at 07:00, 2 years ago EUROAPI and Priothera enter into CDMO collaboration to advance oncology project EUROAPI and Priothera have entered a 5-year CDMO collaboration to advance an innovative oncology molecule for blood cancers, aiming to improve CAR-T cell therapies EUROAPI Priothera Mocravimod CDMO Collaboration Oncology Project
BRIEF published on 06/06/2024 at 17:58, 2 years ago EUROAPI accélère les discussions de financement pour le projet FOCUS-27 Financement Transformation Stratégique EUROAPI FOCUS-27
BRIEF published on 06/06/2024 at 17:58, 2 years ago EUROAPI Accelerates Financing Discussions for FOCUS-27 Project Financing Strategic Transformation EUROAPI FOCUS-27
PRESS RELEASE published on 06/06/2024 at 17:53, 2 years ago Information marché Financement du projet de transformation FOCUS-27 EUROAPI a mandaté un tiers pour le financement de son projet stratégique FOCUS-27. Des progrès importants ont été réalisés. Découvrez les détails de cette démarche Financement EUROAPI FOCUS-27 Mandataire Ad Hoc Projet De Transformation
PRESS RELEASE published on 06/06/2024 at 17:53, 2 years ago Market update : FOCUS-27 transformation project financing EUROAPI appoints mandataire ad hoc for FOCUS-27 project financing discussions, making substantial progress. Learn more about EUROAPI and its active ingredient solutions Project Financing EUROAPI FOCUS-27 Mandataire Ad Hoc Active Ingredient Solutions
BRIEF published on 06/06/2024 at 07:05, 2 years ago EUROAPI Reaches Major Health IPCEI Milestone with Official Notification from European Commission Pharmaceutical Industry European Commission EUROAPI IPCEI Public Funding
BRIEF published on 06/06/2024 at 07:05, 2 years ago EUROAPI franchit une étape majeure de l'IPCEI en matière de santé avec une notification officielle de la Commission européenne Industrie Pharmaceutique EUROAPI Commission Européenne IPCEI Financement Publique
PRESS RELEASE published on 06/06/2024 at 07:00, 2 years ago EUROAPI reaches major Health IPCEI milestone with official notification from European Commission EUROAPI selected for EUR 1 billion IPCEI funding by European Commission to enhance pharmaceutical sector competitiveness and sustainability European Commission R&D EUROAPI IPCEI Pharmaceutical Sector
Published on 06/27/2026 at 16:50, 4 hours 17 minutes ago Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 19 hours 27 minutes ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 21 hours 7 minutes ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 22 hours 7 minutes ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 22 hours 17 minutes ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/27/2026 at 00:05, 21 hours 1 minute ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 21 hours 2 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 21 hours 31 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 21 hours 31 minutes ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 21 hours 39 minutes ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
